文献速递MDS 与骨髓增殖性肿瘤贫血与红细胞疾病

TET2缺陷导致依赖干细胞因子的功能异常红系祖细胞克隆性扩增

TET2 deficiency leads to stem cell factor-dependent clonal expansion of dysfunctional erythroid progenitors.
PubMed 文献 · Blood · 2018-09-25

本研究探讨TET2缺陷如何导致骨髓增生异常综合征(MDS)中无效红系造血。TET2缺陷早期引起依赖干细胞因子(SCF)的红系集落形成单位(CFU-E)细胞过度增殖和分化受损,可被c-Kit抑制剂逆转,机制涉及c-Kit磷酸化增加及磷酸酶SHP-1表达降低。后期出现一群表面标志类似正常CFU-E但功能异常的「标志CFU-E」细胞,其增殖需SCF和促红细胞生成素(EPO),AXL表达增加导致AKT和ERK活化增强,AXL抑制剂可部分逆转其增殖和分化异常。

要点

  • TET2缺陷早期导致依赖SCF的CFU-E细胞过度增殖和分化受损,c-Kit抑制剂可逆转。
  • TET2缺陷后期积累表面标志类似正常CFU-E但功能异常的「标志CFU-E」细胞。
  • 标志CFU-E细胞AXL表达增加,AXL抑制剂可部分逆转其增殖和分化异常。

核心结论

  • TET2在红系造血中起重要作用,TET2缺陷通过此前未知的机制导致无效红系造血。

研究设计与样本

  • 本文为实验研究,使用人CFU-E细胞探讨TET2缺陷对红系造血的影响。

主要发现

  • TET2缺陷早期导致依赖SCF的人CFU-E细胞过度增殖和分化受损,可被c-Kit抑制剂逆转。
  • 上述改变源于c-Kit磷酸化增加,伴随c-Kit负调控因子磷酸酶SHP-1表达降低。
  • TET2缺陷后期导致一群表面标志类似正常CFU-E但功能不同的祖细胞积累,称为「标志CFU-E」细胞。
  • 正常CFU-E细胞仅需EPO即可增殖,而标志CFU-E细胞需SCF和EPO且分化受损。
  • 标志CFU-E细胞AXL表达增加,导致AKT和ERK活化增强,AXL抑制剂可部分逆转其增殖和分化异常。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myelodysplastic syndromes (MDSs) are clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis. Anemia is the defining cytopenia of MDS patients, yet the molecular mechanisms for dyserythropoiesis in MDSs remain to be fully defined. Recent studies have revealed that heterozygous loss-of-function mutation of DNA dioxygenase TET2 is 1 of the most common mutations in MDSs and that TET2 deficiency disturbs erythroid differentiation. However, mechanistic insights into the role of TET2 on disordered erythropoiesis are not fully defined. Here, we show that TET2 deficiency leads initially to stem cell factor (SCF)-dependent hyperproliferation and impaired differentiation of human colony-forming unit-erythroid (CFU-E) cells, which were reversed by a c-Kit inhibitor. We further show that this was due to increased phosphorylation of c-Kit accompanied by decreased expression of phosphatase SHP-1, a negative regulator of c-Kit. At later stages, TET2 deficiency led to an accumulation of a progenitor population, which expressed surface markers characteristic of normal CFU-E cells but were functionally different. In contrast to normal CFU-E cells that require only erythropoietin (EPO) for proliferation, these abnormal progenitors required SCF and EPO and exhibited impaired differentiation. We termed this population of progenitors "marker CFU-E" cells. We further show that AXL expression was increased in marker CFU-E cells and that the increased AXL expression led to increased activation of AKT and ERK. Moreover, the altered proliferation and differentiation of marker CFU-E cells were partially rescued by an AXL inhibitor. Our findings document an important role for TET2 in erythropoiesis and have uncovered previously unknown mechanisms by which deficiency of TET2 contributes to ineffective erythropoiesis.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Qu X, Zhang S, Wang S, et al. TET2 deficiency leads to stem cell factor-dependent clonal expansion of dysfunctional erythroid progenitors. Blood. 2018. PMID: 30254129. doi:10.1182/blood-2018-05-853291

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。